Skip to content

Role of Nityavirechana and Vaitarana Basti in Sciatica

A Comparative study on effect of Nitya Virechana over Vaitarana Basti in Vata Kaphaja Gridhrasi wrt sciatica A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037585
Enrollment
40
Registered
2021-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

None listed

Sponsors

Dr Chinmayi I Koppad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with signs and symptoms of VataKaphaja Gridhrasi wrt sciatica severity index SLR test positive at 30 degree to 90 degree VAS scale 3 to 10

Exclusion criteria

Exclusion criteria: History of spinal surgery and vertebral fracture Evidence of systemic diseases like uncontrolled diabetes, Hypertension, Ischemic heart disease etc Established tumours/malignancy. Patients having back pain due to non-spinal causes will excluded e.g., Urinary tract infection, gastrointestinal disease and uterine diseases like Pelvic inflammatory disease. Patients who have been contraindicated for Nitya Virechana and Basti Subjects with symptoms of red flag signs

Design outcomes

Primary

MeasureTime frame
Nitya Virechana in Gridhrasi is proved to be more effective than Vaitarana Basti Vata-Kaphaja Gridhrasi (w.r.t Sciatica)Timepoint: 0th day to 5th day on each day

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Vishwanath Wasedar

KAHERs Shri B M K Ayurveda Mahavidyalaya

chinnukoppad494@gmail.com9481755494

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026